News Snapshot:
An experimental COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac is 91.25 per cent effective, a Turkish health official said on Thursday. Dr. Serhat Unal, an infectious disease expert serving on Turkey's medical board, said the finding is based on early results of late-stage trials in the country and added that the vaccine is safe. CoronaVac is a so-called inactivated vaccine developed by Sinovac Biotech. Unal announced the initial results following randomised trials involving 7,371 volunteers. Turkey's Health Minister Fahrettin Koca said in the press conference the results were the first to be announced for CoronaVac. Media reports said Sinovac...
